Wafra Investment Advisory Group Inc Ny Lowers stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Wafra Investment Advisory Group Inc Ny reduced its stake in UnitedHealth Group Inc by 1.99% during the most recent quarter end. The investment management company now holds a total of 218,227 shares of UnitedHealth Group Inc which is valued at $28,151,283 after selling 4,434 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on May 10, 2016.UnitedHealth Group Inc makes up approximately 3.19% of Wafra Investment Advisory Group Inc Ny’s portfolio.

Other Hedge Funds, Including , Blackrock Investment Management reduced its stake in UNH by selling 348,350 shares or 6.3% in the most recent quarter. The Hedge Fund company now holds 5,180,380 shares of UNH which is valued at $668,269,020. UnitedHealth Group Inc makes up approx 0.88% of Blackrock Investment Management’s portfolio. Richard Bernstein Advisors sold out all of its stake in UNH during the most recent quarter. The investment firm sold 33,643 shares of UNH which is valued $4,442,222.Evercore Wealth Management boosted its stake in UNH in the latest quarter, The investment management firm added 43,780 additional shares and now holds a total of 484,486 shares of UnitedHealth Group Inc which is valued at $63,971,531. UnitedHealth Group Inc makes up approx 2.85% of Evercore Wealth Management’s portfolio.

UnitedHealth Group Inc opened for trading at $128.75 and hit $130.86 on the upside on Monday, eventually ending the session at $130.64, with a gain of 1.27% or 1.64 points. The heightened volatility saw the trading volume jump to 24,66,033 shares. Company has a market cap of $124,213 M.

On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .Company shares were Reiterated by FBR Capital on Apr 19, 2016 to “Outperform”, Firm has raised the Price Target to $ 145 from a previous price target of $130 .Company shares were Reiterated by Mizuho on Mar 15, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $131 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.